Novartis AG (0QLR)

London
Currency in CHF
96.94
-2.02(-2.04%)
Closed

0QLR Income Statement

Advanced Income Statement
Period Ending:
2015
31/12
2016
31/12
2017
31/12
2018
31/12
2019
31/12
2020
31/12
2021
31/12
2022
31/12
2023
31/12
2024
31/12
Total Revenues
aa.aaaa.aaaa.aaaa.aaaa.aa49,89843,97443,46146,66051,722
Total Revenues Growth
aa.aaaa.aaaa.aaaa.aaaa.aa+2.51%-11.87%-1.17%+7.36%+10.85%
Cost Of Revenues
aa.aaaa.aaaa.aaaa.aaaa.aa15,12111,39111,58212,02012,815
Gross Profit
aa.aaaa.aaaa.aaaa.aaaa.aa34,77732,58331,87934,64038,907
Gross Profit Growth
aa.aaaa.aaaa.aaaa.aaaa.aa+1.53%-6.31%-2.16%+8.66%+12.32%
Gross Profit Margin %
aa.aaaa.aaaa.aaaa.aaaa.aa69.7%74.1%73.35%74.24%75.22%
Other Operating Expenses, Total
aa.aaaa.aaaa.aaaa.aaaa.aa24,62521,62022,66621,99822,587
Other Operating Expenses, Total Growth
R&D Expenses
Selling General & Admin Expenses
Other Operating Expenses
aa.aaaa.aaaa.aaaa.aaaa.aa-2.15%-12.2%+4.84%-2.95%+2.68%
aa.aaaa.aaaa.aaaa.aaaa.aa8,9808,2599,1729,0119,511
aa.aaaa.aaaa.aaaa.aaaa.aa14,19712,75612,19312,48912,564
aa.aaaa.aaaa.aaaa.aaaa.aa1,4486051,301498512
Operating Income
aa.aaaa.aaaa.aaaa.aaaa.aa10,15210,9639,21312,64216,320
Operating Income Growth
aa.aaaa.aaaa.aaaa.aaaa.aa+11.73%+7.99%-15.96%+37.22%+29.09%
EBIT Margin %
aa.aaaa.aaaa.aaaa.aaaa.aa20.35%24.93%21.2%27.09%31.55%
Net Interest Expenses
aa.aaaa.aaaa.aaaa.aaaa.aa-778-717-423-228-438
Net Interest Expenses Growth
aa.aaaa.aaaa.aaaa.aaaa.aa-28.6%+7.84%+41%+46.1%-92.11%
Interest Expense, Total
aa.aaaa.aaaa.aaaa.aaaa.aa-869-787-800-855-1,006
Interest And Investment Income
aa.aaaa.aaaa.aaaa.aaaa.aa9170377627568
Other Non Operating Expenses, Total
aa.aaaa.aaaa.aaaa.aaaa.aa50415,229-346-210-311
EBT, Excl. Unusual Items
aa.aaaa.aaaa.aaaa.aaaa.aa9,87825,4758,44412,20415,571
Gain (Loss) On Sale Of Assets
aa.aaaa.aaaa.aaaa.aaaa.aa-724-22545
Other Unusual Items, Total
aa.aaaa.aaaa.aaaa.aaaa.aa--880--2,250-1,567
EBT, Incl. Unusual Items
aa.aaaa.aaaa.aaaa.aaaa.aa9,87824,5307,1779,12313,640
EBT, Incl. Unusual Items Growth
aa.aaaa.aaaa.aaaa.aaaa.aa+10.49%+148.33%-70.74%+27.11%+49.51%
EBT, Incl. Unusual Items Margin
aa.aaaa.aaaa.aaaa.aaaa.aa19.8%55.78%16.51%19.55%26.37%
Income Tax Expense
aa.aaaa.aaaa.aaaa.aaaa.aa1,8071,6251,1285511,701
Net Income to Company
aa.aaaa.aaaa.aaaa.aaaa.aa8,07124,0186,95514,85411,939
Minority Interest
aa.aaaa.aaaa.aaaa.aaaa.aa13--42
Net Income
aa.aaaa.aaaa.aaaa.aaaa.aa8,07224,0216,95514,85011,941
Net Income Growth
aa.aaaa.aaaa.aaaa.aaaa.aa-31.2%+197.58%-71.05%+113.52%-19.59%
Net Income Margin %
aa.aaaa.aaaa.aaaa.aaaa.aa16.18%54.63%16%31.83%23.09%
Preferred Dividend and Other Adjustments
aa.aaaa.aaaa.aaaa.aaaa.aa-----
Net Income to Common Excl. Extra Items
aa.aaaa.aaaa.aaaa.aaaa.aa8,07222,9086,0498,56811,941
Basic EPS - Continuing Operations
aa.aaaa.aaaa.aaaa.aaaa.aa3.5410.212.774.135.92
Basic EPS - Continuing Operations Growth
aa.aaaa.aaaa.aaaa.aaaa.aa+13.7%+188.15%-72.85%+48.76%+43.41%
Diluted EPS - Continuing Operations
aa.aaaa.aaaa.aaaa.aaaa.aa3.5210.142.764.15.87
Diluted EPS - Continuing Operations Growth
aa.aaaa.aaaa.aaaa.aaaa.aa+14.29%+188.07%-72.78%+48.55%+43.17%
Basic Weighted Average Shares Outstanding
aa.aaaa.aaaa.aaaa.aaaa.aa2,277.042,242.62,181.182,076.792,018.28
Diluted Weighted Average Shares Outstanding
aa.aaaa.aaaa.aaaa.aaaa.aa2,2962,2602,1972,0922,035
Dividend Per Share
aa.aaaa.aaaa.aaaa.aaaa.aa3.393.43.463.923.86
Dividend Per Share Growth
aa.aaaa.aaaa.aaaa.aaaa.aa+8.68%+0.29%+1.77%+13.24%-1.44%
EBITDA
aa.aaaa.aaaa.aaaa.aaaa.aa14,93215,63313,94017,51820,662
EBITDA Growth
aa.aaaa.aa